Peli BioThermal, the global name in temperature controlled packaging, was announced as winner of the Bioprocessing Excellence in Passive Packaging Solutions in Korea at a leading Asia awards ceremony celebrating excellence within the biopharma industry.
Peli BioThermal won the prestigious award after being acknowledged as biopharma “industry leaders and trend-setters” at the 9th Annual Biologics Manufacturing Korea 2020 – Korea Bioprocessing Excellence Awards (KBEA).
Benson Teo, Peli BioThermal’s Senior Director of Sales, Asia, said: “We are very proud to be announced again as award winners in Asia and it is a significant achievement to be the recipients of another major award, which recognises our outstanding excellence within the sector.
“We are thrilled this latest accolade highlights the exceptional high performance of our passive packaging solutions and further demonstrates how Peli BioThermal continues to lead the way within the industry in Asia and globally, with its innovative award-winning thermal protection shipper solutions and exceptional services.”
The award win was announced as Peli BioThermal continues to expand its growing network of facilities within Asia, having recently unveiled its latest new drop point and network station situated in Incheon, South Korea. The new facility is part of the company’s ongoing expansion of more than 100 major sites located globally to best serve the life sciences sector.
The virtual awards ceremony was held on 22nd October in conjunction with the 9th Annual Biologics Manufacturing Korea 2020 conference, which saw more than 600 representatives from Korea’s leading biologic manufacturers, companies and organisations gather for the KBEA awards event.
Visit www.pelibiothermal.com to learn more about the wide range of Peli BioThermal products and offerings.
Peli BioThermal is a division of Peli Products, S.L.U., which is the European arm of Pelican Products, Inc., which is a portfolio company of Behrman Capital, a private equity investment firm based in New York and San Francisco.